Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma

Published:2022-10 Issue:5 Volume:5 Page:577-584
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Pignot Géraldine,Thiery-Vuillemin Antoine,Albigès Laurence,Walz Jochen,Lang Hervé,Balssa Loïc,Parier Bastien,Geoffrois Lionnel,Bensalah Karim,Schlürmann Friederike,Ladoire Sylvain,Bigot Pierre,Borchiellini Delphine,Cassuto Ophélie,Thibault Constance,Ingels Alexandre,Saldana Véronique,Roubaud Guilhem,Bernhard Jean-Christophe,Gravis Gwenaelle,Barthélémy Philippe

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference22 articles.

1. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma;Mejean;N Engl J Med,2018

2. Surgical management of advanced and metastatic renal cell carcinoma: a multidisciplinary approach;Shinder;Front Oncol,2017

3. Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial;Bex;JAMA Oncol,2019

4. Surgical safety of cytoreductive nephrectomy following sunitinib: results from the multicentre, randomised controlled trial of immediate versus deferred nephrectomy (SURTIME);De Bruijn;Eur Urol,2019

5. Cure in advanced renal cell cancer: is it an achievable goal?;Sabanathan;Oncologist,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell Carcinomas;Clinical Genitourinary Cancer;2024-10

2. Conséquences chirurgicales et anatomopathologiques de l’immunothérapie préopératoire en onco-urologie;Bulletin du Cancer;2024-09

3. Upfront versus deferred cytoreductive nephrectomy following targeted or immunotherapy: a population-based propensity score-matched analysis of perioperative complications;World Journal of Urology;2024-07-27

4. Complete response of metastatic RCC with caval vein thrombus following treatment with pembrolizumab and axitinib: is it possible to extend the indications for systemic therapy?;Minerva Urology and Nephrology;2024-06

5. Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial;Journal for ImmunoTherapy of Cancer;2024-06